| Date Filed | Type | Description |
| 06/28/2023 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 37,500 options to buy
@ $1.85, valued at
$69.4k
|
|
| 06/28/2023 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 06/28/2023 |
4
| Loren Stefan (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 06/28/2023 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 06/28/2023 |
4
| Chanan-Khan Asher (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 03/16/2023 |
4
| Shustov Andrei (Senior Vice President, Medical) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.67, valued at
$167k
|
|
| 03/16/2023 |
3
| Shustov Andrei (Senior Vice President, Medical) has filed a Form 3 on Cellectar Biosciences, Inc. |
| 01/18/2023 |
4
| Longcor Jarrod (COO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 144,000 options to buy
@ $1.68, valued at
$241.9k
|
|
| 01/18/2023 |
4
| CARUSO JAMES V (President and CEO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 261,000 options to buy
@ $1.68, valued at
$438.5k
|
|
| 01/18/2023 |
4
| Kolean Chad J (CFO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 104,000 options to buy
@ $1.68, valued at
$174.7k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/01/2022 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 11,700 options to buy
@ $0 |
|
| 08/01/2022 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 7,800 options to buy
@ $0 |
|
| 08/01/2022 |
4
| Loren Stefan (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 7,800 options to buy
@ $0 |
|
| 08/01/2022 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 7,800 options to buy
@ $0 |
|
| 08/01/2022 |
4
| Chanan-Khan Asher (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 7,800 options to buy
@ $0 |
|
| 04/15/2022 |
3/A
| Kolean Chad J (CFO) has filed a Form 3/A on Cellectar Biosciences, Inc. |
| 02/24/2022 |
4
| Kolean Chad J (CFO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.49, valued at
$73.5k
|
|
| 02/24/2022 |
3
| Kolean Chad J (CFO) has filed a Form 3 on Cellectar Biosciences, Inc. |
| 01/27/2022 |
4
| Longcor Jarrod (Chief Business Officer) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 475,000 options to buy
@ $0.55, valued at
$261.3k
|
|
| 01/27/2022 |
4
| Elefant Dov (CFO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 422,000 options to buy
@ $0.55, valued at
$232.1k
|
|
| 01/27/2022 |
4
| CARUSO JAMES V (President and CEO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 1,419,000 options to buy
@ $0.55, valued at
$780.5k
|
|
| 09/14/2021 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Bought 25,000 shares
@ $1.04, valued at
$26k
|
|
| 09/07/2021 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Bought 19,417 shares
@ $1.0426, valued at
$20.2k
|
|
| 07/02/2021 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 117,000 options to buy
@ $1.19, valued at
$139.2k
|
|
| 07/02/2021 |
4
| Loren Stefan (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 78,000 options to buy
@ $1.19, valued at
$92.8k
|
|
| 07/02/2021 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 78,000 options to buy
@ $1.19, valued at
$92.8k
|
|
| 07/02/2021 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 78,000 options to buy
@ $1.19, valued at
$92.8k
|
|
| 07/02/2021 |
4
| Chanan-Khan Asher (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 78,000 options to buy
@ $1.19, valued at
$92.8k
|
|
| 07/02/2021 |
3
| Chanan-Khan Asher (Director) has filed a Form 3 on Cellectar Biosciences, Inc. |
| 03/19/2021 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Sold 58,640 options to buy
@ $30.4, valued at
$1.8M
Sold 23,232 options to buy
@ $30.4, valued at
$706.3k
|
|
| 03/16/2021 |
4
| NEIS JOHN (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Sold 41,155 options to buy
@ $30.4, valued at
$1.3M
Sold 11,200 options to buy
@ $30.4, valued at
$340.5k
Sold 100,515 options to buy
@ $30.4, valued at
$3.1M
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|